Facts & figures

As of:  January, 2016
1) primarily from public funds (EU, Federal Government, State Government); according to Campus Buch: total funding since 1992
2) primarily from own ressources, since 2001

3) primarily from own ressources

4) since 2009
5)since 2006

Research Institutions of Campus Berlin-Buch
Employees (total)

of these:    
Max Delbrück Center for Molecular Medicine (MDC): 1,624  
Leibniz Institute of Molecular Pharmacology (FMP): 275  
Klinische Forschung Charité Campus Buch: 192  
Budget and third-party grants (total)1 EUR 144 million  
Max Delbrück Center for Molecular Medicine (MDC): EUR 104 million  
Leibniz Institute of Molecular Pharmacology (FMP): EUR 24 million  
Klinische Forschung Charité Campus Buch: EUR 16 million  
BiotechPark Berlin-Buch    
Number of companies: 63  
Employees: 800  
Annual revenue:
Percentage of third-party grants: 3,1%

EUR 160 million
Hospitals & Patient-Care Institutions    
Employees (total):
of these:
HELIOS Klinikum Berlin-Buch: 2,550  
Evangelische Lungenklinik: 314  
Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik):
Patient-care institutions: 450  
Number of patient beds: 1232  
Patients per year (inpatient and outpatient): 199,400  
Total investment volume
of these:
EUR 1.219 billion  
Infrastructure Campus Berlin-Buch1 EUR 502 million  
HELIOS Klinikum Berlin-Buch² EUR 304 million  
Evangelische Lungenklinik3 EUR 49 million  
Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik)1
EUR 38 million
LudwigPark3 EUR 45 million  
Allées des Châteaux3 EUR 23 million  
Widerker Vermögensverwaltung (Schlosspark-Passage)3
EUR 28 million
Housing construction associations (HOWOGE3,4, EWG3,5, Hau+S3,5)
EUR 120 million
Ludwig Hoffmann Quartier EUR 110 million  

News Buch Berlin

Eckert & Ziegler: Seed Implantation for Prostate Cancer Receives Reimbursement for Outpatient Care

Seed implantation for prostate cancer is now to be reimbursed as an outpatient treatment by public health insurances in Germany. This was decided by the Federal Joint Committee (G-BA) with effect from...

more ...

Enhanced speed, contrast, and information: New contrast mechanism improves xenon MRI

Xenon magnetic resonance imaging offers deep insights into the human body and opens up new possibilities in the diagnosis and treatment of diseases.

more ...

A potent weapon against lymphomas

MDC researchers have developed a new approach to CAR T-cell therapy. The team has shown in Nature Communications that the procedure is very effective, especially when it comes to fighting follicular l...

more ...

Events Buch Berlin

14.09.2021, 09:00
GMP Biotech Summer School

Good Manufacturing Practice (GMP) Basic Course Biotechnology (English)

more ...

This website is supported by: